Table 1. Correlation between the protein expression of METTL3 and clinicopathological features in 180 cases of NSCLC.
| Factors | METTL3 protein expression (n=180) | P value | |
|---|---|---|---|
| Low expression (n=90) | High expression (n=90) | ||
| Age | 0.5509 | ||
| <60 years | 46 | 42 | |
| ≥60 years | 44 | 48 | |
| Gender | 0.7656 | ||
| Male | 46 | 44 | |
| Female | 44 | 46 | |
| TNM stage | <0.0001 | ||
| I–II | 64 | 25 | |
| III–IV | 26 | 65 | |
| DDP | <0.0001 | ||
| Sensitive | 78 | 12 | |
| Resistant | 12 | 78 | |
| Lymph node metastasis | <0.0001 | ||
| Yes | 18 | 70 | |
| No | 72 | 20 | |
| Smoking status | 0.8815 | ||
| Smoker | 46 | 45 | |
| Non-smoker | 44 | 45 | |
METTL3, methyltransferase-like 3; NSCLC, non-small cell lung cancer; DDP, cisplatin.